S-phenyl benzenethiosulfinate | 4409-79-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: S-phenyl benzenethiosulfinate
• 英文别名: diphenylthio ether；phenylthio-ether；Phenylthio ether；phenylsulfanyloxysulfanylbenzene
• CAS: 4409-79-4
• 化学式: C₁₂H₁₀OS₂
• 分子量: 234.343
• InChiKey: SNZXFRFQGXSSGN-UHFFFAOYSA-N

物化性质

• 沸点：
  349.7±25.0 °C(Predicted)
• 密度：
  1.26±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  59.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  苯次磺酸,乙酯 在 氢碘酸 作用下， 以 水 为溶剂， 以90%的产率得到S-phenyl benzenethiosulfinate
  参考文献：
  名称：

  Acid-catalyzed reduction of a sulfenate ester by iodide

  摘要：

  DOI：

  10.1016/s0040-4039(00)94418-6

文献信息

• DIRECT ANTI-MARKOVNIKOV ADDITION OF ACIDS TO ALKENES
  申请人：THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL

  公开号：US20160096791A1

  公开（公告）日：2016-04-07

  A method of making an anti-Markovnikov addition product, comprises reacting an acid with an alkene or alkyne in a dual catalyst reaction system to the exclusion of oxygen to produce said anti-Markovnikov addition product; the dual catalyst reaction system comprising a single electron oxidation catalyst in combination with a hydrogen atom donor catalyst. Dual catalyst composition useful for carrying out such methods are also described.

  一种制备反马尔科夫尼科夫加成产物的方法，包括在排除氧气的双催化剂反应体系中，使酸与烯烃或炔烃发生反应，以产生所述反马尔科夫尼科夫加成产物；所述双催化剂反应体系包括单电子氧化催化剂与氢原子给体催化剂的组合。还描述了用于执行此类方法的双催化剂组合物。
• Substituted azepino[4,5b] indoline derivatives
  申请人：——

  公开号：US20020077318A1

  公开（公告）日：2002-06-20

  The invention provides compounds of Formula (I): 1 wherein R 1 -R 4 , p and q have any of the values described in the specification, as well as pharmaceutical salts thereof, and pharmaceutical compositions containing such compounds or salts. The compounds and salts are 5-HT ligands and are useful for treating diseases, disorders, and/or conditions in a mammal wherein activity of a 5-HT receptor is implicated. The compounds and salts are particularly useful for treating diseases of the central nervous system.

  该发明提供了Formula (I)的化合物： 其中R1-R4，p和q的取值如规范中描述的任何值，以及其药用盐，以及含有这种化合物或盐的药用组合物。这些化合物和盐是5-HT配体，对于治疗哺乳动物中涉及5-HT受体活性的疾病、紊乱和/或症状是有用的。这些化合物和盐特别适用于治疗中枢神经系统疾病。
• Tricyclic delta-opioid modulators
  申请人：Dax Scott

  公开号：US20060030585A1

  公开（公告）日：2006-02-09

  The invention is directed to delta opioid receptor modulators. More specifically, the invention relates to tricyclic δ-opioid modulators. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.

  这项发明涉及δ阿片受体调节剂。更具体地，该发明涉及三环δ-阿片调节剂。还描述了利用该发明的化合物治疗轻度至严重疼痛和各种疾病的药用和兽医组合物以及方法。
• Coupling of nucleophiles, vinyl compounds or CO with water, alcohols or amines to organic compounds
  申请人：——

  公开号：US20010037042A1

  公开（公告）日：2001-11-01

  Process for the coupling of a) nucleophiles selected from the group alcohols, thioles, amines, metallised hydrocarbons, CH-acidic compounds and metal cyanides, or of b) carbon monoxide mixed with water, alcohols, ammonia, primary or secondary amines, to organic compounds selected from the group of leaving-group-containing aromatics, hetero-aromatics with a C-bonded leaving group, aromatic or hetero-aromatic methyl compounds with a leaving group bonded to the methyl group, ethylenically unsaturated organic compounds with a C-bonded leaving group, or organic allyl compounds with a leaving group in allyl position, or c) vinyl compounds with leaving-group-containing aromatics, whilst cleaving the leaving group in the presence of Pd complexes with monophospholine ligands as the catalyst, whereby variants b) and c) are carried out in the presence of an inorganic base or organic nitrogen base, the process being characterised in that the Pd complex contains secondary monophosphines with aliphatic, branched or cyclic substituents as ligands.

  将a）亲核试剂（选择自羟基、硫醇、胺、金属化的碳氢化合物、CH-酸性化合物和金属氰化物中的一种）或b）与水、醇、氨、一级或二级胺混合的一氧化碳，与含有离去基团的芳香族化合物、带有C键合离去基团的杂环芳香族化合物、带有离去基团键合到甲基基团的芳香族或杂环芳香族甲基化合物、带有C键合离去基团的乙烯不饱和有机化合物，或带有离去基团的有机烯丙基化合物中的有机化合物耦合的过程，或c）含有离去基团的乙烯化合物，同时在Pd配合物存在下在单膦磷酮配体作为催化剂的情况下裂解离去基团，其中变体b）和c）在无机碱或有机氮碱存在下进行，所述过程的特征在于Pd配合物含有带有脂肪、支链或环状取代基的二级单膦磷酮作为配体。
• SULFONIC AMIDE AND SULFOXIMINE-SUBSTTTUTED DIARYL-DIHYDROPYRIMIDINONES AND USAGE THEREOF
  申请人：Von Nussbaum Franz

  公开号：US20120094968A1

  公开（公告）日：2012-04-19

  The present application relates to novel sulfonamidw- or sulfoximine-substituted 1,4-diaryldihydropyrimidin-2-one derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system.

  本申请涉及新型磺胺基或亚砜基取代的1,4-二芳基二氢嘧啶-2-酮衍生物，以及它们的制备方法，它们单独或组合用于治疗和/或预防疾病，以及用于制备治疗和/或预防疾病的药物，特别是用于治疗和/或预防肺部和心血管系统疾病的用途。